Kinnate Biopharma Inc
(KNTE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 21,569 | 17,481 | 13,719 | 10,503 | 7,626 |
| Operating Income | -21,569 | -17,481 | -13,719 | -10,503 | -7,626 |
| Other Income | 124 | 24 | 12 | 4 | 12 |
| Pre-tax Income | -21,445 | -17,457 | -13,707 | -10,499 | -7,614 |
| Net Income Continuous | -21,445 | -17,457 | -13,707 | -10,499 | -7,614 |
| Net Income | $-21,445 | $-17,457 | $-13,707 | $-10,499 | $-7,614 |
| EPS Basic Total Ops | -0.49 | -0.40 | 0.64 | -2.80 | -2.05 |
| EPS Basic Continuous Ops | -0.49 | -0.40 | 0.64 | -2.80 | -2.05 |
| EPS Diluted Total Ops | -0.49 | -0.40 | 0.64 | -2.80 | -2.05 |
| EPS Diluted Continuous Ops | -0.49 | -0.40 | 0.64 | -2.80 | -2.05 |
| EBITDA(a) | $-20,997 | $-17,174 | $-13,690 | $-10,480 | $-7,606 |